Targeting SLC transporters: small molecules as modulators and therapeutic opportunities

A Schlessinger, N Zatorski, K Hutchinson… - Trends in Biochemical …, 2023 - cell.com
Solute carrier (SLCs) transporters mediate the transport of a broad range of solutes across
biological membranes. Dysregulation of SLCs has been associated with various …

Emerging roles of the human solute carrier 22 family

SW Yee, KM Giacomini - Drug Metabolism and Disposition, 2022 - ASPET
The human solute carrier 22 family (SLC22), also termed the organic ion transporter family,
consists of 28 distinct multi-membrane spanning proteins, which phylogenetically cluster …

Cyclodextrins applied to the treatment of lysosomal storage disorders

Y Ishitsuka, T Irie, M Matsuo - Advanced Drug Delivery Reviews, 2022 - Elsevier
Cyclodextrin (CD), a cyclic oligosaccharide, is a pharmaceutical additive that improves the
solubility of hydrophobic compounds. Recent research has focused on the potential active …

New and emerging research on solute carrier and ATP binding cassette transporters in drug discovery and development: outlook from the international transporter …

KM Giacomini, SW Yee, ML Koleske… - Clinical …, 2022 - Wiley Online Library
Enabled by a plethora of new technologies, research in membrane transporters has
exploded in the past decade. The goal of this state‐of‐the‐art article is to describe recent …

[HTML][HTML] Clinical trials for gene therapy in lysosomal diseases with CNS involvement

C Sevin, K Deiva - Frontiers in Molecular Biosciences, 2021 - frontiersin.org
There are over 70 known lysosomal storage disorders (LSDs), most caused by mutations in
genes encoding lysosomal hydrolases. Central nervous system involvement is a hallmark of …

[HTML][HTML] Models to study basic and applied aspects of lysosomal storage disorders

Á Gaudioso, TP Silva, MD Ledesma - Advanced Drug Delivery Reviews, 2022 - Elsevier
The lack of available treatments and fatal outcome in most lysosomal storage disorders
(LSDs) have spurred research on pathological mechanisms and novel therapies in recent …

The lysosomal membrane—export of metabolites and beyond

S Rudnik, M Damme - The FEBS Journal, 2021 - Wiley Online Library
Lysosomes are degradative organelles in eukaryotic cells mediating the hydrolytic
catabolism of various macromolecules to small basic building blocks. These low‐molecular …

[PDF][PDF] A recurrent gain-of-function mutation in CLCN6, encoding the ClC-6 Cl−/H+-exchanger, causes early-onset neurodegeneration

MM Polovitskaya, C Barbini, D Martinelli… - The American Journal of …, 2020 - cell.com
Dysfunction of the endolysosomal system is often associated with neurodegenerative
disease because postmitotic neurons are particularly reliant on the elimination of …

[HTML][HTML] Neurodegeneration upon dysfunction of endosomal/lysosomal CLC chloride transporters

S Bose, H He, T Stauber - Frontiers in Cell and Developmental …, 2021 - frontiersin.org
The regulation of luminal ion concentrations is critical for the function of, and transport
between intracellular organelles. The importance of the acidic pH in the compartments of the …

[HTML][HTML] Unconventional functions of amino acid transporters: Role in macropinocytosis (SLC38A5/SLC38A3) and diet-induced obesity/metabolic syndrome (SLC6A19 …

YD Bhutia, M Mathew, S Sivaprakasam… - Biomolecules, 2022 - mdpi.com
Amino acid transporters are expressed in mammalian cells not only in the plasma
membrane but also in intracellular membranes. The conventional function of these …